This article has Open Peer Review reports available.
Intraoperative bispectral index monitoring and time to extubation after cardiac surgery: secondary analysis of a randomized controlled trial
© Vance et al.; licensee BioMed Central Ltd. 2014
Received: 15 May 2014
Accepted: 16 September 2014
Published: 18 September 2014
Fast track recovery is a care process goal after cardiac surgery. Intraoperative anesthetic depth may impact recovery, but the impact of brain monitoring on time to extubation and intensive care unit (ICU) length of stay after cardiac surgery has not been extensively studied. Our goal was to determine if BIS-guided anesthesia improves time to extubation compared to MAC-guided anesthesia in a cardiac surgery population.
In this secondary outcome analysis of a randomized controlled study, we analyzed 294 patients undergoing elective coronary bypass grafting, valve replacements, and bypass plus valve replacements at a single tertiary referral center between February 1, 2009 and April 30, 2010. We analyzed cardiac surgery patients that had been randomized to BIS-guided anesthesia alerts (n = 131) or MAC-guided anesthesia alerts (n = 163). The primary outcome measure was time to extubation in the BIS-guided and anesthetic concentration-guided groups. Secondary outcomes were length of stay in the ICU and total postoperative hospital length of stay.
Valid extubation time data were available for 247 of 294 patients. The median [IQR] time to extubation was 307 [215 to 771] minutes in the BIS group and 323 [196 to 730] minutes in the anesthetic concentration group (p = 0.61). The median [IQR] ICU length of stay was 54 [29 to 97] hours versus 70 [44 to 99] hours (p = 0.11). In terms of postoperative hospital length of stay, there was no difference between the groups with median [IQR] times of 6 [5-8] days (p = 0.69) in each group.
The use of intraoperative BIS monitoring during cardiac surgery did not change time to extubation, ICU length of stay or hospital length of stay. Data regarding BIS monitoring and recovery in an exclusively cardiac surgery population are consistent with recent effectiveness studies in the general surgical population.
ClinicalTrials.gov number NCT00689091.
The past two decades have seen an increasing interest in early endotracheal extubation after cardiac surgery, typically defined as extubation within 8 hours of the end of surgery. Early extubation is associated with decreased intensive care unit (ICU) length of stay (LOS), hospital LOS, and thus the potential for improved recovery and decreased resource utilization [1, 2]. Risk factors for prolonged intubation include need for inotropic support, excessive bleeding, and atrial arrhythmias; these factors can thus help predict suitability for early extubation . Early extubation has been shown to be safe compared to standard post-cardiac surgery extubation [2, 4, 5]. While intraoperative anesthetic techniques have evolved to emphasize fast track recovery , the role of brain monitoring in extubation and length of stays after cardiac surgery has not been well studied. In the B-Aware , B-Unaware , and BAG-RECALL  trials, the use of BIS monitoring was not associated with a reduction in the amount of anesthesia administered or a decreased hospital length of stay, but only some of the patients in these trials underwent cardiac procedures.
The Bispectral Index (BIS) monitor (Covidien, Boulder, CO, USA) has been used as a surrogate for depth of anesthesia in and has also been posited to improve recovery from surgery and general anesthesia. The BIS monitor could have direct or indirect effects on recovery. In terms of direct effects, initial efficacy studies have demonstrated that BIS monitoring can reduce anesthetic use and, consequently, the time to extubation and other recovery parameters in noncardiac surgery [9, 10]. In other words, consciousness recovers faster by using less anesthetic. However, BIS monitoring could also have indirect effects on recovery across different surgical populations. Such effects could be mediated through cognitive phenotypes that might play a more important role in determining extubation in an ICU setting. For example, a patient with delirium in the ICU may be less likely to be extubated. Thus, if the intraoperative use of the BIS monitor affects intermediate cognitive phenotypes such as postoperative delirium, it could alter the time to extubation in the postoperative period of critical care. Indeed, a recent study reported on the protective odds ratio conferred by BIS-guided anesthesia when studying postoperative delirium in cardiac surgical patients . In a recent study of noncardiac patients, it was shown that BIS-guided anesthesia was associated with a reduction in the concentration of anesthetics delivered, with improvements in cognition at three months after surgery . Thus, the intraoperative use of the BIS monitor has been linked to a number of outcomes that extend far into the postoperative period. As such, we hypothesized that the use of the BIS monitor during cardiac surgery could also have relevance to the postoperative period in terms of reducing recovery times. The primary aim of this study was to determine whether the intraoperative use of the BIS improved time to extubation after cardiac surgery compared to an anesthetic concentration protocol. Secondary outcomes included differences in length of stay in the intensive care unit and total postoperative length of stay in the hospital.
Study design and patient cohort
The Michigan Awareness Control Study (MACS; ClinicalTrials.gov Trial Registration Number NCT00689091) was a randomized controlled effectiveness trial comparing alerting protocols based on the BIS (trigger for BIS > 60) and anesthetic concentrations (minimum alveolar concentration [MAC] <0.5). The trial included adults undergoing general anesthesia for an unselected surgical population. The major conclusion of MACS was that there was no detectable difference in the incidence of definite awareness or recovery variables between monitoring protocols based on either BIS values or anesthetic concentration . The current study is a secondary analysis of cardiac patients from this cohort and ethical approval (HUM00044647) was provided by the Institutional Review Board of the University of Michigan, Ann Arbor, USA (Chairperson Michael Geisser) on 26 September 2011. Patient consent was waived as this was a secondary analysis of de-identified data. Eligible patients included all elective coronary bypass grafting (CABG), valve replacements, and CABG plus valve replacements that were part of the primary study lasting from February 1, 2009 until April 30, 2010. Time during recruitment differs from the parent study because recruitment of patients at the Cardiovascular Center of the University of Michigan Health System began later than other study sites. Exclusion criteria included emergency cases, aortic dissections, or hypothermic circulatory arrest cases, since these cases are typically not candidates for early extubation.
Perioperative data were collected using Centricity® (General Electric Healthcare, Waukesha, WI, USA), an anesthesia information management system. All information is entered by anesthesia personnel (residents, fellows, nurse anesthetists and attendings). For each data point, the user may select from a predefined list or enter free-text information to describe any clinical variable. A history and physical examination is electronically documented for every case. Additional information was obtained from the Society of Thoracic Surgeons (STS) National Cardiac Database. The database collects more than 350 variables from approximately 95 percent of all adult cardiac surgery centers throughout the United States. Each site voluntarily enters patient data using pre-specified definitions and certified software systems; the data are sent semiannually to the STS Data Warehouse and Analysis Center at the Duke Clinical Research Institute. The data subsequently undergo a series of quality checks before being included in the national sample.
Patients underwent surgery either via a median sternotomy or via a thoracotomy (for redo mitral valve operations or patients’ cosmetic-driven request). All cases were performed using cardiopulmonary bypass (CPB), with antegrade and/or retrograde cardioplegia for myocardial protection. CPB utilized nonpulsatile flow for all cases. Heparin was administered to achieve and maintain an activated clotting time >450s. Both nasal and bladder temperature probes were placed for monitoring, and the patient’s temperature was reduced to between 32-35°C during CPB. After termination of CPB, protamine 1–1.3 mg/100 units heparin was administered. All patients were transported to the ICU intubated once hemodynamically stable.
Anesthetic technique and interventions
Induction of anesthesia was performed with midazolam, fentanyl, pancuronium, with or without propofol or etomidate, titrated to loss of consciousness and muscle relaxation. Anesthesia was subsequently maintained with isoflurane, and additional fentanyl and pancuronium as needed. Isoflurane was continued during cardiopulmonary bypass. All patients were sedated with propofol infusions at varying rates at the end of the case; sedation was continued in the ICU until the patients were weaned for tracheal extubation.
In the Michigan Awareness Control Study, patients were randomized to a BIS-guided group or MAC-guided group. Automated pages were sent to the intraoperative anesthesia provider when the median BIS rose above 60 for a 5-minute epoch or when the effective age-adjusted MAC fell below 0.5 (in the MAC-guided group). There was no lower value alert for the BIS group and no upper value alert for the MAC-guided group.
The primary outcome measure for the current study was the time to extubation across the two groups (BIS-guided, MAC-guided). Secondary outcomes included length of stay in the ICU and total postoperative length of stay in the hospital. We also compared the groups in terms of factors that could impede early extubation, including vasopressor usage at the end of the case and excessive bleeding, for which we used intraoperative blood product usage as a surrogate. We defined high blood product utilization as greater than 3 units of fresh frozen plasma (FFP) or greater than 4 units of packed red blood cells (pRBCs). We arrived at these values based on previous studies of average blood utilization in cardiac surgery [14–16].
Statistical analysis was performed using SPSS statistics version 19 (IBM Corp, Somers, NY, USA). Data from the anesthesia information system and the STS database from our institution were merged together for all patients that met the inclusion criteria using a third-party honest broker system. After the merge was completed, all identifiers were removed prior to analysis by the study team. Patients without valid data in both the anesthesia information system and the STS database were excluded from this analysis. The Kolmogorov-Smirnov statistic was used to determine normality for all continuous data elements. If the p-value was significant (<0.05), the assumption of normality was violated and a non-parametric test (Mann Whitney U test) was used. For categorical variables, a two-tailed Pearson chi-square or Fisher’s Exact test were used as appropriate. A p-value of <0.05 was considered statistically significant.
MAC (N = 163)
BIS (N = 131)
0.86 to 2.30
Body mass index (median)
0.97 to 1.88
0.47 to 2.78
0.84 to 2.12
0.20 to 1.21
Stroke/transient ischemic attack
0.35 to 2.30
0.42 to 1.21
0.91 to 2.96
0.38 to 2.60
0.48 to 1.33
0.52 to 2.34
0.64 to 1.72
0.66 to 1.71
0.52 to 2.34
Chronic obstructive pulmonary disease
Other lung disease
0.77 to 5.43
0.48 to 3.85
Valvular heart disease
0.58 to 1.47
Coronary artery disease
0.82 to 2.07
Congestive heart failure
0.55 to 1.58
0.61 to 1.82
0.71 to 2.12
0.68 to 2.14
0.15 to 1.21
Peripheral vascular disease
0.67 to 5.57
0.40 to 3.99
Previous difficult intubation
Limited mouth opening
0.50 to 9.02
Limited thyromental distance
0.32 to 2.07
Limited neck flexion
Limited neck extension
Limited jaw protrusion
Intraoperative view grade 3 or 4
Intraoperative mask grade 3 or 4
Minimum alveolar concentration
Time to extubation (min)
307 [215 to 771]
323 [196 to 730]
Intensive care unit length of stay (hrs)
54 [29 to 97]
70 [44 to 99]
Hospital length of stay (days)
Intraoperative high blood product utilization
High blood product utilization
0.63 to 2.10
Intraoperative FFP >3 units
0.71 to 3.98
Intraoperative pRBCs >4 units
0.55 to 1.88
Total anesthesia time
Minimum alveolar concentration
Total time under anesthesia (minutes)
363 [304 to 445]
346 [290 to 413]
High vasopressor requirements
High vasopressor requirements (number of patients and % of total)
0.72 to 2.12
This study did not identify a statistically significant difference in time to extubation after cardiac surgery between BIS-guided and MAC-guided groups, which were well matched in terms of comorbidities. There were also no statistically significant differences in ICU or total postoperative hospital lengths of stay.
In non-cardiac surgery patients, initial efficacy studies suggested that BIS-monitoring may decrease time to extubation [9, 10]. However, subsequent analysis  of large effectiveness studies did not show that BIS confers a benefit in overall time to recovery. Time to extubation following cardiac surgery has been an area of research in many studies, but few involve brain monitoring. Ender, et al.  have described how the implementation of goal-focused processes (creation of a specific cardiac-recovery post-anesthesia care unit (PACU) and modifying intraoperative anesthesia) can greatly decrease time to extubation in selected patients (stable hemodynamics without inotropic support, no excessive bleeding, and normothermia). Gooi et al.  showed that the preoperative identification of a lower-risk patient cohort allowed for earlier extubation in that fast-track group. However, neither study utilized brain monitoring.
Wong, et al.  showed that increased age, female sex, use of inotropes, excessive bleeding, atrial arrhythmias, and presence of an intra-aortic balloon pump were associated with increased times to extubation. These variables represent potential confounders, but the groups in our study showed no difference in age, sex, vasopressor use, excessive bleeding, or dysrhythmias (Table 1). Also, the groups were similar in the median age-adjusted MAC and total anesthesia time (Table 4) showing that the anesthetic depth or duration had no effect on extubation times.
Although most time-to-extubation studies in cardiac surgery patients have not included brain monitoring, a secondary analysis by Villafranca, et al. from the BAG-RECALL trial demonstrated that the use of a BIS protocol during cardiac surgery in a Canadian hospital did not improve extubation time compared to a protocol based on age-adjusted 0.7 MAC . A power analysis showed that 50 patients in each group would be required to detect a 30 minute difference in extubation time at a power of 0.95. Both their study and the present investigation greatly exceed 50 patients in each cohort. The current study confirms the previous findings and adds to the literature by demonstrating comparable results in a separate population with a protocol based on an even lower MAC threshold (age-adjusted 0.5 MAC). Thus, two independently conducted analyses of larger randomized controlled trials suggest no clear benefit to intraoperative BIS monitoring during cardiac surgery relative to the outcome of early extubation. Our study additionally demonstrates no difference in the secondary outcomes of ICU length of stay or overall hospital stay. As BIS is not routinely employed in our ICU, it cannot be concluded from the current study whether BIS monitoring in the ICU is beneficial for earlier extubation time.
There are limitations to this study. First, as noted, the BIS monitor was not continued in the ICU to monitor depth of sedation postoperatively. Furthermore, at our institution, there is no set dose and no strict protocol that dictates depth of sedation. However, we note that a study in which ICU propofol doses were not different between groups, the use of a BIS monitor was not associated with shorter time to extubation . Second, patients who arrive late in the evening are often sedated and intubated overnight because of staffing issues when they may have otherwise been extubated. Thus, time to extubation or ICU length of stay are potentially skewed by these confounds. In a previous study, it was shown that patients who were admitted to the ICU in the evening tended to be intubated longer independent of comorbidities and surgical factors [18, 19]. Third, this was a secondary outcome analysis of a prospective trial with a primary outcome of intraoperative awareness with explicit recall; data regarding recovery and length of stay must therefore be interpreted cautiously. However, our approach of secondary analysis eliminates any practitioner bias of trying to achieve the outcome of early extubation. Fourth, our anesthetic practice in cardiac surgery does not routinely involve total intravenous anesthesia; results may be different in this population. Finally, because the initial trial involved awareness prevention, there were no lower limit alarms for BIS and upper limit alarms for MAC, which might have altered anesthetic management in a way that influenced time to extubation. However, a similar secondary analysis of a BIS vs. MAC alarm trial that incorporated both upper and lower BIS limits similarly failed to find an association between BIS utilization and time to extubation after cardiac surgery .
There was no difference in time to extubation between BIS-guided and MAC-guided anesthetics in a patient population well matched for comorbidities and for potential confounders for prolonged intubation. There also were no statistically significant differences in ICU and total post-operative hospital length of stay. Data from the current study are impactful because they suggest that the use of the BIS monitor during cardiac surgery does not confer an advantage over anesthetic-concentration guided protocols in earlier extubation times.
Assistance with the article: George Mashour and Michael Avidan for helpful review of the manuscript.
The Michigan Awareness Control Study (parent trial) was generously funded by the Cerebral Function Monitoring grant from the Foundation for Anesthesia Education and Research/American Society of Anesthesiologists, the National Institutes of Health, Bethesda (KL2 RR024987-01), and the Department of Anesthesiology, University of Michigan.
- London MJ, Shroyer AL, Coll JR, MaWhinney S, Fullerton DA, Hammermeister KE, Grover FL: Early extubation following cardiac surgery in a veterans population. Anesthesiol. 1998, 88: 1447-1458. 10.1097/00000542-199806000-00006.View ArticleGoogle Scholar
- Cheng DC, Karski J, Peniston C, Raveendran G, Asokumar B, Carroll J, David T, Sandler A: Early tracheal extubation after coronary artery bypass graft surgery reduces costs and improves resource use. A prospective, randomized, controlled trial. Anesthesiol. 1996, 85: 1300-1310. 10.1097/00000542-199612000-00011.View ArticleGoogle Scholar
- Wong DT, Cheng DC, Kustra R, Tibshirani R, Karski J, Carroll-Munro J, Sandler A: Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score. Anesthesiol. 1999, 91: 936-944. 10.1097/00000542-199910000-00012.View ArticleGoogle Scholar
- Ender J, Borger MA, Scholz M, Funkat AK, Anwar N, Sommer M, Mohr FW, Fassl J: Cardiac surgery fast-track treatment in a postanesthetic care unit: six-month results of the Leipzig fast-track concept. Anesthesiol. 2008, 109: 61-66. 10.1097/ALN.0b013e31817881b3.View ArticleGoogle Scholar
- Chong JL, Grebenik C, Sinclair M, Fisher A, Pillai R, Westaby S: The effect of a cardiac surgical recovery area on the timing of extubation. J Cardiothorac Vasc Anesth. 1993, 7: 137-141. 10.1016/1053-0770(93)90205-Y.View ArticlePubMedGoogle Scholar
- Myles PS, Leslie K, McNeil J, Forbes A, Chan MT: Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004, 363: 1757-1763. 10.1016/S0140-6736(04)16300-9.View ArticlePubMedGoogle Scholar
- Kertai MD, Pal N, Palanca BJ, Lin N, Searleman SA, Zhang L, Burnside BA, Finkel KJ, Avidan MS: Association of perioperative risk factors and cumulative duration of low bispectral index with intermediate-term mortality after cardiac surgery in the B-Unaware Trial. Anesthesiol. 2010, 112: 1116-1127. 10.1097/ALN.0b013e3181d5e0a3.View ArticleGoogle Scholar
- Avidan MS, Jacobsohn E, Glick D, Burnside BA, Zhang L, Villafranca A, Karl L, Kamal S, Torres B, O'Connor M, Evers AS, Gradwohl S, Lin N, Palanca BJ, Mashour GA: Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med. 2011, 365: 591-600. 10.1056/NEJMoa1100403.View ArticlePubMedGoogle Scholar
- Gan TJ, Glass PS, Windsor A, Payne F, Rosow C, Sebel P, Manberg P, BIS Utility Study Group: Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology. 1997, 87: 808-815. 10.1097/00000542-199710000-00014.View ArticlePubMedGoogle Scholar
- Song D, Joshi GP, White PF: Titration of volatile anesthetics using bispectral index facilitates recovery after ambulatory anesthesia. Anesthesiol. 1997, 87: 842-848. 10.1097/00000542-199710000-00018.View ArticleGoogle Scholar
- Whitlock EL, Torres BA, Lin N, Helsten DL, Nadelson MR, Mashour GA, Avidan MS: Postoperative delirium in a substudy of cardiothoracic surgical patients in the BAG-RECALL clinical trial. Anesth Analg. 2014, 118: 809-817. 10.1213/ANE.0000000000000028.View ArticlePubMedPubMed CentralGoogle Scholar
- Chan MT, Cheng BC, Lee TM, Gin T: BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013, 25: 33-42. 10.1097/ANA.0b013e3182712fba.View ArticlePubMedGoogle Scholar
- Mashour GA, Shanks A, Tremper KK, Kheterpal S, Turner CR, Ramachandran SK, Picton P, Schueller C, Morris M, Vandervest JC, Lin N, Avidan MS: Prevention of intraoperative awareness with explicit recall in an unselected surgical population: a randomized comparative effectiveness trial. Anesthesiol. 2012, 117: 717-725. 10.1097/ALN.0b013e31826904a6.View ArticleGoogle Scholar
- Renton MC, McClelland DB, Sinclair CJ: Use of blood products in cardiac surgery. Perfusion. 1997, 12: 157-162. 10.1177/026765919701200302.View ArticlePubMedGoogle Scholar
- Hardy JF, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M: The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth. 1991, 38: 511-517. 10.1007/BF03007591.View ArticlePubMedGoogle Scholar
- Tyson GS, Sladen RN, Spainhour V, Savitt MA, Ferguson TB, Wolfe WG: Blood conservation in cardiac surgery. Preliminary results with an institutional commitment. Ann Surg. 1989, 209: 736-742. 10.1097/00000658-198906000-00011.View ArticlePubMedPubMed CentralGoogle Scholar
- Fritz BA, Rao P, Mashour GA, Abdallah AB, Burnside BA, Jacobsohn E, Zhang L, Avidan MS: Postoperative recovery with bispectral index versus anesthetic concentration-guided protocols. Anesthesiology. 2013, 118: 1113-1122. 10.1097/ALN.0b013e31828604ab.View ArticlePubMedGoogle Scholar
- Gooi J, Marasco S, Rowland M, Esmore D, Negri J, Pick A: Fast-track cardiac surgery: application in an Australian setting. Asian Cardiovasc Thorac Ann. 2007, 15: 139-143. 10.1177/021849230701500212.View ArticlePubMedGoogle Scholar
- Villafranca A, Thomson IA, Grocott HP, Avidan MS, Kahn S, Jacobsohn E: The impact of bispectral index versus end-tidal anesthetic concentration-guided anesthesia on time to tracheal extubation in fast-track cardiac surgery. Anesth Analg. 2013, 116: 541-548. 10.1213/ANE.0b013e31827b117e.View ArticlePubMedGoogle Scholar
- Anderson J, Henry L, Hunt S, Ad N: Bispectral index monitoring to facilitate early extubation following cardiovascular surgery. Clin Nurse Spec. 2010, 24: 140-148. 10.1097/NUR.0b013e3181d82a48.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2253/14/79/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.